Citalopram Hydrobromide
Product Images NDC 70934-127

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram Hydrobromide (NDC 70934-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6ead67b1 Fded 47fc Bdee 45be43fd96e9 01)

FDA Label Image

Logo (6ead67b1 Fded 47fc Bdee 45be43fd96e9 02)

FDA Label Image

Logo (6ead67b1 Fded 47fc Bdee 45be43fd96e9 03)

FDA Label Image

70934 127 30 Master Bottle Label Approval Rev B 10 19

70934 127 30 Master Bottle Label Approval   Rev B 10 19
NDC 70934-127-30 corresponds to Citalopram Tablets, USP. However, the rest of the text is not readable and some characters appear to be non-English. Therefore, a useful description cannot be generated.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.